CTEP 9557: A dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF mutant solid tumors.-MedSci.cn - 梅斯（MedSci）

CTEP 9557: A dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF mutant solid tumors.

Mooradian, M; Cleary, JM; Cohen, JV; Lawrence, DP; Buchbinder, EI; Giobbie-Hurder, A; Parikh, AR; Shapiro, G; Darville, L; Smalley, K; Koomen, JM; Newton, A; Keer, HN; Ivy, SP; Chen, HX; Sullivan, RJ

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):

科室
- - 订阅+
  - 更多科室
工具
服务